Article
Glioblastoma-initiating cell heterogeneity generated by the cell-of-origin, genetic/epigenetic mutation and microenvironment.
Seminars in cancer biology - 1 Jul 2022
Kondo Toru
Abstract excerpt
Glioblastoma (GBM) and other malignant tumours consist of heterogeneous cancer cells, including GBM-initiating cells (GICs). This heterogeneity is likely to arise from the following: different sets of genetic mutations and epigenetic modifications, which GICs gain in the transformation process; differences in cells of origin, such as stem cells, precursor cells or differentiated cells; and the cancer...
Topics
- Brain Neoplasms
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Endothelial Cells
- Epigenesis, Genetic
- Glioblastoma
- Humans
- Mutation
- Neoplastic Stem Cells
- Tumor Microenvironment
